Explore MeiraGTx late-stage gene therapy catalysts, manufacturing edge, cash runway to 2H 2028, plus key risks—read the full ...
FRONT-2 global enrollment completed approximately 4 months ahead of initial projections4FRONT-2 over-enrolled (anticipated N>500), with final ...
FRONT-2 global enrollment completed approximately 4 months ahead of initial projections4FRONT-2 over-enrolled (anticipated N>500), with final patient randomization expected in Q3 2026, reflecting stro ...
Discusses Updated Phase 1/2 Data for NGN-401 Gene Therapy in Rett Syndrome June 29, 2026 8:00 AM EDTCompany ParticipantsLina ...
Officials are urging people to use precaution against mosquito bites, since West Nile has no cure ...
AINewsWire Editorial Coverage: A tectonic shift is reshaping global semiconductor manufacturing. Hundreds of billions of dollars i ...
The U.S. Army has achieved a significant milestone in counter-unmanned aerial systems (C-UAS) technology ...